bioMerieux (FR:BIM) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
bioMerieux, a major player in the diagnostics industry, has disclosed its total number of voting rights and shares for May 2024, revealing a total of 118,361,220 shares and 191,117,859 theoretical voting rights.
For further insights into FR:BIM stock, check out TipRanks’ Stock Analysis page.
